RE:Catalyst Doccole wrote: What catalysts will help this stock grow? Insider buys bumped it, now back to stagnant. Thoughts?
If you are looking for potential items that could move the stock ... here are a few things to think about ...
1. 346 (acute) fast-track application and then a further acceptance from FDA 60 days later (assuming we get it)
2. 352 details to emerge - large unmet need in acute ??? Also any fast-track to go with that ???
3. chronic regimen update and further timelines on development
4. IBD candidate selection - and next steps
5. New drug development update - new drugs added to the mix
6. Sale of CITA
7. Further partnering with Nuance on acute - maybe Nuance doubles down - unlikely but what if the two sides can come to some agreement to add acute
End of November or early December corporate update (maybe we can still expect this) with a new presentation to cover some of the above items ... or other missed items.
Just some thoughts to begin a conversation.